Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Tc-99m-sestamibi thyroid uptake in euthyroid individuals and in patients with autoimmune thyroid disease
Author: Santos, AO
Zantut-Wittmann, DE
Nogueira, RO
Etchebehere, ECSC
Lima, MCL
Tambascia, MA
Camargo, EE
Ramos, CD
Abstract: Purpose: We investigated the biokinetics of Tc-99m-sestamibi in the thyroid of euthyroid volunteers (EVs) and in patients with autoimmune thyroid diseases and determined the best time interval between Tc-99m-sestamibi injection and calculation of uptake. Methods: Forty EVs, 30 patients with Graves' disease (GD), 15 patients with atrophic Hashimoto's thyroiditis (AHT) and 15 patients with hypertrophic Hashimoto's thyroiditis (HHT) underwent Tc-99m-sestamibi thyroid scintigraphy. Dynamic images were acquired for 20 min, and static images were obtained 20 min, 60 min and 120 min post injection. Five-, 20-, 60- and 120-min uptake, time to maximal uptake (T-max) and T-1/2 of tracer clearance were calculated. Thyroid hormones and antibodies were measured. Tc-99m-pertechnetate uptake was investigated in GD patients. Results: T-max was approximately 5 min in all four groups. The mean T-1/2 value for EVs was similar to the GD value and lower than the HHT and AHT values. The mean (+/- SD) 5-min uptake was 0.13% (+/- 0.05%) for EVs. The 5-min uptake in GD was higher than that in EVs(P < 0.001) and correlated with free thyroxine (r=0.54) and with Tc-99m-pertechnetate uptake (r=0.68). Uptake in HHT was higher than that in AHT (P=0.0003) and EVs (P=0.002). Uptake in AHT was lower than uptake in EVs (P=0.0001). Conclusion: Five minutes is the optimal time interval between Tc-99m-sestamibi injection and calculation of thyroid uptake. Five-minute uptake differentiates euthyroid individuals from GD patients. There is a high correlation between Tc-99m-sestamibi and Tc-99m-pertechnetate uptake in GD. The reduced Tc-99m-sestamibi uptake in AHT patients is probably due to glandular destruction and fibrosis. Inflammatory infiltrate and high mitochondrial density in thyrocytes possibly explain the increased uptake in GD and HHT.
Subject: Tc-99m-sestamibi
Graves's disease
Hashimoto's thyroiditis
Country: EUA
Editor: Springer
Citation: European Journal Of Nuclear Medicine And Molecular Imaging. Springer, v. 32, n. 6, n. 702, n. 707, 2005.
Rights: fechado
Identifier DOI: 10.1007/s00259-004-1728-1
Date Issue: 2005
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000229506400012.pdf132.45 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.